Persistent Opioid Consumption After Major Abdominal Surgery and Its Determinants
POCAS
1 other identifier
observational
700
1 country
2
Brief Summary
The opioid crisis is a growing problem around the world, with prescription opioids being a major contributor to this crisis. They can be prescribed in different chronic and acute settings, such as surgery. This is therefore an event which may mark a first exposure to opioids in many opioid-naive patients and be associated with subsequent long-term use. This long-term persistent opioid consumption (POC) after surgery may be due, among other things, to chronic postsurgical pain (CPSP). Many risk factors have been identified in the development of chronic pain. Some are related to the surgery while others are related to patient characteristics. Of these, preoperative opioid use, pre-existing pain, and psychological history are major factors that increase the risk of POC or CPSP. The population having undergone major abdominal surgery remains poorly represented in studies of postoperative POC. It can be reasonable to think that these patients may have a similar high risk of CPSP and POC as other surgical patients. The potential harmful effects of POC and CPSP may limit the recovery of these patients and impair their quality of life (QoL). The risk factors for CPSP are important to consider when considering POC. While psychological factors related to pain have been shown to be associated with postoperative pain and analgesic use, the association between unrelieved postoperative pain and POC may have been underestimated. Regional anesthesia is frequently used in major abdominal surgery to reduce the risk of acute and chronic postoperative pain. However, data regarding CPSP specifically after major abdominal surgery are lacking, and the role of neuraxial analgesia on its prevention and on postoperative opioid use is unclear. Since little is known about the prevalence of POC after major abdominal surgery and its determinants, the investigators propose to conduct a major abdominal surgery cohort study by examining POC and CPSP using information reported by patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2022
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 5, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2022
CompletedStudy Start
First participant enrolled
February 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFebruary 12, 2025
February 1, 2025
2.1 years
January 5, 2022
February 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Patient-reported opioid use
Any consumption of opioids as declared by patients during the 7 days prior to the 3-month interview
3 months after surgery
Secondary Outcomes (2)
Presence of chronic pain and its assessment by BPI
3 months after surgery
Change in quality of life assessed by SF-12
3 months after surgery
Study Arms (1)
Patients undergoing major abdominal surgery
The investigators aim to conduct a prospective observational, cohort study including all patients undergoing a major open abdominal surgery.
Interventions
Participants will complete pain and quality of life questionnaires. Opioid consumption will also be assessed using validated questionnaires.
Eligibility Criteria
The investigators aim to conduct a prospective cohort study. This study will take place at the Centre Hospitalier de l'Université de Montréal (CHUM) and CIUSSS de l'Est-de-l'Île-de-Montréal (Maisonneuve-Rosemont Hospital)
You may qualify if:
- Patients undergoing major open abdominal surgery during the study period (6 months)
- Patients suffering from chronic pain or using opioids may be included since they are at risk of developing CPSP or POC
You may not qualify if:
- Patients who have already participated in the study will be excluded as well as patients who will undergo a second surgery after discharge from hospital and before the 90-day deadline for the primary endpoint.
- Patients undergoing appendectomies, inguinal hernia repair and abdominal wall hernia repair other than incisional hernias.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CIUSS-de-l'Est-de-l'Île-de-Montréal (Hôpital Maisonneuve-Rosemont)
Montreal, Quebec, H1T 2M4, Canada
Centre Hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, H2X 3E4, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François Martin Carrier, MD, PhD
Centre hospitalier de l'Université de Montréal (CHUM)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 5, 2022
First Posted
January 19, 2022
Study Start
February 13, 2022
Primary Completion
March 14, 2024
Study Completion
September 30, 2024
Last Updated
February 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share